North America Automated Liquid Handling Market Size to register a growth of 6.9% CAGR

20-11-2018 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report North America Automated Liquid Handling Market, published by KBV research, the North America Automated Liquid Handling Market would witness market growth of 6.9% CAGR during the forecast period (2018 – 2024).

The Standalone market would dominate the North America Automated Liquid Handling Market Type by 2024, growing at a CAGR of 6.7 % during the forecast period. The Individual Benchtop Workstation market is expected to witness a CAGR of 5.8% during (2018 - 2024). Additionally, The Multi-Instrument System market is expected to witness highest CAGR of 8% during (2018 - 2024).

The US market dominated the North America Disposable Tips Automated Liquid Handling Market by Country 2017, thereby, achieving a market value of $174.7 million by 2024. The Canada market is expected to witness a CAGR of 6.9% during (2018 - 2024). Additionally, The Mexico market is expected to witness a CAGR of 8.9% during (2018 - 2024).

The Biotechnology & Pharmaceutical Companies market dominated the Mexico Automated Liquid Handling Market by End User 2017, thereby, achieving a market value of $21.1 million by 2024, The Contract Research Organizations market is expected to witness a CAGR of 10.3% during (2018 - 2024). Additionally, The Academic & Government Research Institutes market is expected to witness highest CAGR of 9.7% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/north-america-automated-liquid-handling-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Illumina, Inc., Thermo Fisher Scientific, Inc., Abcam Plc., Epizyme, Inc., Agilent Technologies, Qiagen N.V., Merck & Co., (Merck), Active Motif, Diagenode, Inc. and Zymo Research Corporation (Zymo)